glp-1 drugs for inflammation The Era: Why These Intestinal Peptides Are Reshaping Modern Medicine The anti-inflammatory and immunological properties
Description
Associations 1.7
J Coll Physicians Surg Pak
The prevalence of GLP-1 agonist use is notably higher, reaching 43% among adults diagnosed with diabetes, 25% among those with heart disease, and 22% among those recently diagnosed as overweight or obese in the past five years
F., and El Maghraby G
